AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 387 filers reported holding AVANOS MED INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $227,000 | -33.2% | 6,535 | -40.0% | 0.01% | -41.7% |
| Q3 2021 | $340,000 | -23.9% | 10,891 | -11.4% | 0.01% | -25.0% |
| Q2 2021 | $447,000 | -24.7% | 12,289 | -9.5% | 0.02% | -30.4% |
| Q1 2021 | $594,000 | -21.4% | 13,586 | -17.6% | 0.02% | -25.8% |
| Q4 2020 | $756,000 | +38.2% | 16,481 | +0.0% | 0.03% | +24.0% |
| Q3 2020 | $547,000 | +13.0% | 16,475 | -0.0% | 0.02% | +4.2% |
| Q2 2020 | $484,000 | +15.2% | 16,478 | +5.6% | 0.02% | -4.0% |
| Q1 2020 | $420,000 | -18.8% | 15,605 | +1.6% | 0.02% | +8.7% |
| Q4 2019 | $517,000 | +22.8% | 15,355 | +36.7% | 0.02% | +15.0% |
| Q3 2019 | $421,000 | -14.1% | 11,230 | 0.0% | 0.02% | -13.0% |
| Q2 2019 | $490,000 | +25.3% | 11,230 | +22.5% | 0.02% | +21.1% |
| Q1 2019 | $391,000 | +7.1% | 9,165 | +12.5% | 0.02% | -5.0% |
| Q4 2018 | $365,000 | -4.5% | 8,145 | +46.2% | 0.02% | +5.3% |
| Q3 2018 | $382,000 | – | 5,570 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 3,087,229 | $96,322,000 | 4.36% |
| RGM Capital, LLC | 2,521,930 | $78,684,000 | 3.86% |
| Tributary Capital Management, LLC | 322,946 | $10,076,000 | 0.78% |
| Alpha Paradigm Partners, LLC | 52,844 | $1,649,000,000 | 0.66% |
| HEARTLAND ADVISORS INC | 307,416 | $9,591,000 | 0.58% |
| Factorial Partners, LLC | 23,400 | $730,000 | 0.50% |
| Champlain Investment Partners, LLC | 2,082,903 | $64,987,000 | 0.31% |
| WESTWOOD HOLDINGS GROUP INC | 741,503 | $23,135,000 | 0.25% |
| Campbell & CO Investment Adviser LLC | 22,100 | $690,000 | 0.22% |
| AIGEN INVESTMENT MANAGEMENT, LP | 26,488 | $826,000 | 0.16% |